Wikidata

(Q64151642)

English

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
SUSTAIN-2 (English)
0 references
title
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Finland
0 references
France
0 references
Germany
0 references
Lithuania
0 references
Malaysia
0 references
Mexico
0 references
Poland
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
30 September 2015
0 references
end time
28 October 2017
0 references
number of participants
802
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64151642&oldid=2235455690"